Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for complex bronchoscopy under deep sedation or general anesthesia
ChiCTR2500100900Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in hypopnea (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Incidence of perioperative respiratory depression. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
hypopnea
Beyond the preview
Go deeper on ChiCTR2500100900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100900.